CORRELATION BETWEEN PHARMACOKINETICS AND CLINICAL EFFECTS OF ERGOTAMINE IN PATIENTS SUFFERING FROM MIGRAINEALA HURULA V.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 21; NO 5; PP. 397-402; BIBL. 14 REF.Article

BIOAVAILABILITY AND ANTIMIGRAINE EFFICACY OF EFFERVESCENT ERGOTAMINEALA HURULA V.1982; HEADACHE; ISSN 0017-8748; USA; DA. 1982; VOL. 22; NO 4; PP. 167-170; BIBL. 18 REF.Article

TOLFENAMIC ACID AND ERGOTAMINE ABUSEALA HURULA V; MYLLYLA VV; HOKKANEN E et al.1981; HEADACHE; ISSN 0017-8748; USA; DA. 1981; VOL. 21; NO 6; PP. 240-242; BIBL. 10 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE IN HEALTHY SUBJECTS AFTER SINGLE AND REPEATED ORAL DOSESALA HURULA V; MYLLYLAE VV; ARUELA P et al.1980; UPS. J. MED. SCI., SUPPL.; ISSN 0300-9726; SWE; DA. 1980; NO 31; PP. 7-9; BIBL. 8 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER ORAL, RECTAL AND INTRAMUSCULAR ADMINISTRATIONALA HURULA V; MYLLYLA VV; ARVELA P et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 1; PP. 51-55; BIBL. 12 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE IN CONTINUOUS MEDICATIONMYLLYLA VV; ALA HURULA V; ARVELA P et al.1980; UPS. J. MED. SCI., SUPPL.; ISSN 0300-9726; SWE; DA. 1980; NO 31; PP. 20-22; BIBL. 6 REF.Article

JUVENILE AMYTROPHIC LATERAL SCLEROSIS: A REPORT OF TWO CASES IN A SINGLE FAMILYMYLLYLA VV; TOIVAKKA E; ALA HURULA V et al.1979; ACTA NEUROL. SCAND.; DNK; DA. 1979; VOL. 60; NO 3; PP. 170-177; BIBL. 17 REF.Article

SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER THREE SUCCESSIVE DOSES AND DURING CONTINUOUS MEDICATIONALA HURULA V; MYLLYLA VV; ARVELA P et al.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 16; NO 5; PP. 355-360; BIBL. 12 REF.Article